Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v5-EN
Language French English
Date Updated 2020-09-15 2020-06-15
Drug Identification Number 02362449 02362449
Brand name SANDOZ LOSARTAN HCT SANDOZ LOSARTAN HCT
Common or Proper name LOSARTAN HCT LOSARTAN HCT
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 12.5MG 100MG 12.5MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-29 2018-10-29
Estimated end date 2020-08-28 2020-07-24
Actual end date 2020-08-28
Shortage status Resolved Actual shortage
Company comments
Health Canada comments